| Systematic (IUPAC) name | |
|---|---|
| (4R)-3-(5-oxo-L-prolyl)-1,3-thiazolidine-4-carboxylic acid | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| ATC code | L03AX05 |
| PubChem | CID 65944 |
| ChemSpider | 59348 |
| UNII | 785363R681 |
| KEGG | D07261 |
| ChEMBL | CHEMBL1488165 |
| Synonyms | (4R)-3-[(2S)-5-oxopyrrolidine-2-carbonyl]-1,3-thiazolidine-4-carboxylic acid |
| Chemical data | |
| Formula | C9H12N2O4S |
| Mol. mass | 244.26758 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Pidotimod is an immunostimulant.[1]
|
|||||||||||||||||||||||||||||
| This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)